4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-014543
Chief Financial Officer sold 6,359 shares at $103.69 ($659,352)
- Chief Financial Officer acquired 7,828 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Laponis Adam · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Sale : show line 1 in the form | −6,359 | $103.69 | $659,352 | 118,501 | D |
| 2026-11-16 | Grant or award : show line 2 in the form | +7,828 | 126,329 | D | ||
| Open-market sales · 6,359 sh · avg $103.69 · $659,352 | ||||||
Loading xslF345X06/marketforms-74342.xml…